Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-01-07

Clinical Trial Update: Efficacy Study of EVT 201 in the Treatment of Elderly Patients With Daytime Sleepiness [Phase 2]

View source ↗

Summary

Phase 2 efficacy study of EVT 201 for daytime sleepiness in elderly patients with sleep initiation and maintenance disorders has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EVT 201

Snippet

Sponsor: Evotec Neurosciences GmbH | Conditions: Sleep Initiation and Maintenance Disorders | Phase 2 | Status: COMPLETED